Showing results (231-240 of 268) with videos related to

Sort By:
Pageof 27
Oncoimmunology|December 15, 2018
B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodiesHans A Schlößer, Martin Thelen, Axel Lechner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2025
A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignanciesVincent Ribrag, Lara Iglesias, Filippo De Braud, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Germline homozygosity and allelic imbalance of HLA-I are common in esophagogastric adenocarcinoma and impair the repertoire of immunogenic peptidesMaria Alejandra Garcia-Marquez, Martin Thelen, Eugen Bauer, et al.
Cancer Research|April 9, 2009
PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFRMartin L Sos, Mirjam Koker, Barbara A Weir, et al.
International Journal of Cancer|March 8, 2023
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIMThorsten O Goetze, Ralf-Dieter Hofheinz, Timo Gaiser, et al.
Nature Medicine|March 7, 2025
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trialKohei Shitara, Yelena Y Janjigian, Jaffer Ajani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2014
MET amplification status in therapy-naïve adeno- and squamous cell carcinomas of the lungHans-Ulrich Schildhaus, Anne M Schultheis, Josef Rüschoff, et al.
The New England Journal of Medicine|December 9, 2025
Ianalumab plus Eltrombopag in Immune ThrombocytopeniaAdam Cuker, Thomas Stauch, Nichola Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomographyThomas Zander, Matthias Scheffler, Lucia Nogova, et al.
Oncoimmunology|July 29, 2016
Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinomaHans A Schlößer, Uta Drebber, Michael Kloth, et al.
Pageof 27